Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives

Abstract

As the medical landscape changes daily with the coronavirus disease (COVID-19) pandemic, clinical researchers are caught off-guard and are forced to make decisions on research visits in their ongoing clinical trials. Although there is some guidance from local and national organizations, the principal investigator (PI) is ultimately responsible for determining the risk-benefit ratio of conducting, rescheduling, or cancelling each research visit. The PI should take into consideration the ethical principles of research, local/national guidance, the community risk of the pandemic in their locale, staffing strain, and the risk involved to each participant, to ultimately decide on the course of action. While balancing the rights and protection of the human subject, we seldom examine patients’ views and opinions about their scheduled research visit(s). This article discusses the ethical principles of beneficence and autonomy in helping the decision-making process. We discuss ways to weigh-in local and national guidance, staffing strain, and institutional support into the decision-making process and outline potential changes needed for regulatory bodies depending on the decision. Further, we discuss the need to weigh-in the individual risk-benefit ratio for each participant and present a decision tree to navigate this complex process. Finally, we examine participant and caregiver perspectives on their fears, sense of preparedness, and factors that they consider before deciding whether to keep or postpone the research appointments. This entry also provides PIs ways to support their research participants in both scenarios, including provision of psychological support.

Orientação política e apoio ao isolamento social durante a pandemia da COVID-19: evidências do Brasil

“…First, our sample is not representative of the Brazilian population. Given the pressingness of the issue and the data collection restrictions imposed by the virus, the overwhelming majority of studies on the COVID-19 pandemic share this limitation (Di Lorenzo et al, 2020;Marta et al, 2020;Padala, Jendro, & Padala, 2020). Nation-wide data collections with representative samples are therefore needed to attest to the external validity of the phenomenon.…”

Mental Health Effects of COVID-19 Pandemia: A Review of Clinical and Psychological Traits

“…Articles related with other's countries experience during this time. 55 In Paris in s psychiatry department although psychiatrists and psychologists were rather reluctant to embrace telepsychiatry before this crisis, the pandemic has required a shift of 90% of our outpatient activity and liaison psychiatry to telepsychiatry. The good news is that this quick shift is well accepted by patients, psychiatrists, and psychologists.…”

Pandemics and psychiatry: Repositioning research in context of COVID-19

“…If an in-person visit is decided upon, it is important to make sure that all precautions including protective care are fully implemented, and the participants' and researchers' safety carefully monitored. Interestingly, many participants appear to support continuation of medical research during epidemics (Padala et al, 2020).…”